Literature DB >> 31638251

Microarray profile of circular RNAs identifies hsa_circRNA_102459 and hsa_circRNA_043621 as important regulators in oral squamous cell carcinoma.

Wei Deng1, Wei Peng2, Tao Wang1, Jingxin Chen1, Xunding Qiu1, Liangbin Fu1, Shuangxi Zhu2.   

Abstract

Circular RNAs (circRNAs) have emerged as important regulators of carcinogenesis. However, the role of circRNAs in oral squamous cell carcinoma (OSCC) remains limited. Here, total RNAs were extracted from three pairs of OSCC and adjacent normal tissues and subjected to circRNA microarrays to detect the differentially expressed circRNAs. Gene Ontology (GO) and functional category analyses were used to identify circRNAs associated with tumor cell proliferation pathways. Then, gain‑of‑function assays or loss‑of‑function assays were conducted to investigate the functions of the most upregulated and downregulated circRNAs on TSCC1 cell proliferation, cell cycle and apoptosis using CCK‑8 and EdU assays, flow cytometry and Hoechst 33258 staining, respectively. The results revealed that hsa_circRNA_102459 was significantly downregulated and hsa_circRNA_043621 was significantly upregulated in OSCC tissues. Clinical stage, tumor differentiation, lymph node metastasis presented significant difference in regards to the expression of circRNA_043621 and circRNA_102459. The in vitro experiments further demonstrated that upregulation of circRNA_102459 or downregulation of circRNA_043621 significantly suppressed TSCC1 cell proliferation, induced cell cycle G0/G1 phase arrest and promoted apoptosis. Furthermore, the MAPK and PI3K/Akt pathways were suppressed, while Bcl‑2 family members were activated by circRNA_102459 overexpression and circRNA_043621 knockdown. Taken together, our study indicates that differentially expressed circRNAs are closely related to the carcinogenesis of OSCC. Among these, circRNA_102459 and circRNA_043621 may function as a tumor‑suppressor and promoter, respectively, of OSCC carcinogenesis, and thus may be valuable diagnostic biomarkers of OSCC.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31638251     DOI: 10.3892/or.2019.7369

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

1.  Circ_0000745 strengthens the expression of CCND1 by functioning as miR-488 sponge and interacting with HuR binding protein to facilitate the development of oral squamous cell carcinoma.

Authors:  Kuangzheng Li; Xiaosheng Fan; Ziyi Yan; Jia Zhan; Fangyun Cao; Yixia Jiang
Journal:  Cancer Cell Int       Date:  2021-05-21       Impact factor: 5.722

2.  The circRNA_102911/miR-129-5p/SOX6 axis is involved with T lymphocyte immune function in elderly patients with laparoscopic left hepatectomy for hepatolithiasis.

Authors:  Hongqiang Zhao; Xiaoyu Shao; Haorun Liu; Qi Liu; Jiangyang Lu; Weimin Li
Journal:  Exp Ther Med       Date:  2020-12-17       Impact factor: 2.447

3.  Circ-KIAA0907 inhibits the progression of oral squamous cell carcinoma by regulating the miR-96-5p/UNC13C axis.

Authors:  Wenjie Dong; Lei Zhao; Shiyang Zhang; Shijie Zhang; Hongyun Si
Journal:  World J Surg Oncol       Date:  2021-03-14       Impact factor: 2.754

Review 4.  Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression.

Authors:  Chen Xue; Ganglei Li; Juan Lu; Lanjuan Li
Journal:  Signal Transduct Target Ther       Date:  2021-11-24

Review 5.  The Research Progression and Clinical Significance of Circular RNAs in Head and Neck Cancers.

Authors:  Danhui Wang; Zhi Li; Yongjun Wu
Journal:  Biomed Res Int       Date:  2020-10-21       Impact factor: 3.411

6.  Upregulation of circ_0000199 in circulating exosomes is associated with survival outcome in OSCC.

Authors:  Yanwei Luo; Fengxia Liu; Jie Guo; Rong Gui
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379

7.  Blocking circ-SCMH1 (hsa_circ_0011946) suppresses acquired DDP resistance of oral squamous cell carcinoma (OSCC) cells both in vitro and in vivo by sponging miR-338-3p and regulating LIN28B.

Authors:  Feng Qiu; Bin Qiao; Nan Zhang; Zheng Fang; Lu Feng; Shanfeng Zhang; Weiliu Qiu
Journal:  Cancer Cell Int       Date:  2021-08-05       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.